This post was originally published on this siteAdolescents could gain access to the shots for the first time as the Omicron variant spreads through communities and threatens to disrupt schools trying to stay open.
This post was originally published on this siteA third dose of the Pfizer-BioNTech vaccine appears to be as effective against omicron as two doses were against the original variant.
This post was originally published on this sitePfizer and BioNTech said that a third dose of their Covid-19 vaccine neutralized the Omicron variant in lab tests but that the two-dose regimen was significantly less effective at blocking the virus.
COVID booster doses could be authorized by Friday, ‘should be a priority’ for US adults, experts say
This post was originally published on this siteThe CDC has said it’s safe to mix vaccine brands, and data suggests Pfizer-BioNTech or Moderna would be more protective than a second J&J shot.
This post was originally published on this siteThe drug company plans to seek FDA authorization of a treatment that patients could take at home to keep them out of the hospital.
This post was originally published on this siteExperts said the shot could bring relief to parents anxious about their children getting sick, though some worry that those most at risk may slip through the cracks.
States prepare to receive pediatric Pfizer doses ahead of full approval for ages 5-11: Live COVID-19 updates
This post was originally published on this siteStates including Washington and Indiana are expecting to receive hundreds of thousands of pediatric doses of Pfizer’s vaccine next week. Live updates.
This post was originally published on this site A high-level medical panel of US government advisors will meet Tuesday to decide whether to authorize the Pfizer Covid-19 vaccine for children aged five to 11 years old. If, as is widely expected, the independent experts convened by the Food and Drug...
This post was originally published on this siteU.S. health regulators are expected to weigh in soon on the evidence for giving the Pfizer-BioNTech Covid-19 vaccine to children 5 to 11 years old.